214 related articles for article (PubMed ID: 37903626)
21. The role of tristetraprolin in cancer and inflammation.
Sanduja S; Blanco FF; Young LE; Kaza V; Dixon DA
Front Biosci (Landmark Ed); 2012 Jan; 17(1):174-88. PubMed ID: 22201737
[TBL] [Abstract][Full Text] [Related]
22. Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Patial S; Curtis AD; Lai WS; Stumpo DJ; Hill GD; Flake GP; Mannie MD; Blackshear PJ
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1865-70. PubMed ID: 26831084
[TBL] [Abstract][Full Text] [Related]
23. Tristetraprolin as a Therapeutic Target in Inflammatory Disease.
Patial S; Blackshear PJ
Trends Pharmacol Sci; 2016 Oct; 37(10):811-821. PubMed ID: 27503556
[TBL] [Abstract][Full Text] [Related]
24. Phylogenetic distribution and evolution of the linked RNA-binding and NOT1-binding domains in the tristetraprolin family of tandem CCCH zinc finger proteins.
Blackshear PJ; Perera L
J Interferon Cytokine Res; 2014 Apr; 34(4):297-306. PubMed ID: 24697206
[TBL] [Abstract][Full Text] [Related]
25. Plant Polyphenol Gossypol Induced Cell Death and Its Association with Gene Expression in Mouse Macrophages.
Cao H; Sethumadhavan K
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189372
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide regulation of antiinflammatory tristetraprolin family and proinflammatory gene expression in mouse macrophages.
Cao H
BMC Res Notes; 2024 Mar; 17(1):82. PubMed ID: 38504371
[TBL] [Abstract][Full Text] [Related]
27. A unique C-terminal repeat domain maintains the cytosolic localization of the placenta-specific tristetraprolin family member ZFP36L3.
Frederick ED; Ramos SB; Blackshear PJ
J Biol Chem; 2008 May; 283(21):14792-800. PubMed ID: 18367448
[TBL] [Abstract][Full Text] [Related]
28. Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid-derived suppressor cells.
Zhang L; Kwack KH; Thiyagarajan R; Mullaney KK; Lamb NA; Bard JE; Sohn J; Seldeen KL; Arao Y; Blackshear PJ; Abrams SI; Troen BR; Kirkwood KL
FASEB J; 2024 Jan; 38(1):e23338. PubMed ID: 38038723
[TBL] [Abstract][Full Text] [Related]
29. Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression.
Ross EA; Naylor AJ; O'Neil JD; Crowley T; Ridley ML; Crowe J; Smallie T; Tang TJ; Turner JD; Norling LV; Dominguez S; Perlman H; Verrills NM; Kollias G; Vitek MP; Filer A; Buckley CD; Dean JL; Clark AR
Ann Rheum Dis; 2017 Mar; 76(3):612-619. PubMed ID: 27597652
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin.
Horner TJ; Lai WS; Stumpo DJ; Blackshear PJ
Mol Cell Biol; 2009 Apr; 29(8):1999-2010. PubMed ID: 19188452
[TBL] [Abstract][Full Text] [Related]
31. Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence.
Kaplan IM; Morisot S; Heiser D; Cheng WC; Kim MJ; Civin CI
J Immunol; 2011 Mar; 186(5):2826-34. PubMed ID: 21270394
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice.
Saaoud F; Wang J; Iwanowycz S; Wang Y; Altomare D; Shao Y; Liu J; Blackshear PJ; Lessner SM; Murphy EA; Wang H; Yang X; Fan D
Redox Biol; 2020 Oct; 37():101609. PubMed ID: 32591281
[TBL] [Abstract][Full Text] [Related]
33. Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation.
Kang JG; Amar MJ; Remaley AT; Kwon J; Blackshear PJ; Wang PY; Hwang PM
J Immunol; 2011 Sep; 187(5):2696-701. PubMed ID: 21784977
[TBL] [Abstract][Full Text] [Related]
34. Gain-of-Function Mutation of Tristetraprolin Impairs Negative Feedback Control of Macrophages
O'Neil JD; Ross EA; Ridley ML; Ding Q; Tang T; Rosner DR; Crowley T; Malhi D; Dean JL; Smallie T; Buckley CD; Clark AR
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28265004
[TBL] [Abstract][Full Text] [Related]
35. Functional regulation of Zfp36l1 and Zfp36l2 in response to lipopolysaccharide in mouse RAW264.7 macrophages.
Wang KT; Wang HH; Wu YY; Su YL; Chiang PY; Lin NY; Wang SC; Chang GD; Chang CJ
J Inflamm (Lond); 2015; 12():42. PubMed ID: 26180518
[TBL] [Abstract][Full Text] [Related]
36. The roles of TTP and BRF proteins in regulated mRNA decay.
Sanduja S; Blanco FF; Dixon DA
Wiley Interdiscip Rev RNA; 2011; 2(1):42-57. PubMed ID: 21278925
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages.
Jalonen U; Nieminen R; Vuolteenaho K; Kankaanranta H; Moilanen E
Mediators Inflamm; 2006; 2006(6):40691. PubMed ID: 17392586
[TBL] [Abstract][Full Text] [Related]
38. Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages.
Joe Y; Kim HJ; Kim S; Chung J; Ko MS; Lee WH; Chang KC; Park JW; Chung HT
J Biol Chem; 2011 Jul; 286(28):24735-42. PubMed ID: 21606497
[TBL] [Abstract][Full Text] [Related]
39. The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages.
Tudor C; Marchese FP; Hitti E; Aubareda A; Rawlinson L; Gaestel M; Blackshear PJ; Clark AR; Saklatvala J; Dean JL
FEBS Lett; 2009 Jun; 583(12):1933-8. PubMed ID: 19416727
[TBL] [Abstract][Full Text] [Related]
40. Tristetraprolin Overexpression in Non-hematopoietic Cells Protects Against Acute Lung Injury in Mice.
Choudhary I; Vo T; Bathula CS; Lamichhane R; Lewis BW; Looper J; Jeyaseelan S; Blackshear PJ; Saini Y; Patial S
Front Immunol; 2020; 11():2164. PubMed ID: 32983182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
